- Home
- LSF vs ELUT Comparison
LSF vs ELUT Comparison
Compare LSF & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSF | ELUT |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3M | 35.6M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LSF | ELUT |
|---|---|---|
| Price | $2.12 | $0.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.17 | N/A |
| AVG Volume (30 Days) | 33.6K | ★ 75.6K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 75.28 | ★ 146.77 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $49,889,286.00 | $12,293,000.00 |
| Revenue This Year | $188.00 | N/A |
| Revenue Next Year | $32.35 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.23 | N/A |
| 52 Week Low | $1.96 | $0.50 |
| 52 Week High | $5.11 | $1.39 |
Technical Indicators
Market Signals| Indicator | LSF | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 24.81 | 46.42 |
| Support Level | $1.96 | $0.75 |
| Resistance Level | $3.55 | $0.87 |
| Average True Range (ATR) | 0.29 | 0.07 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 30.26 | 46.17 |
Price Performance
Historical ComparisonAbout LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the development and marketing of food and beverage products focused on health and wellness. The company's product portfolio includes coffee creamers, coffee, tea, hot chocolate, hydration and beverage enhancement products, and snacks, made using natural and functional ingredients.
About ELUT Elutia Inc.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.